Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

155.40 +0.88 (+0.57%)
Official Closing Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
99 100 Next >
3 Stocks to Safeguard Your Investments During a Market Meltdown
Discover how investing in these leading defensive stocks in pharmaceuticals and restaurants can shield portfolios against market downturns. 
Via InvestorPlace
The Time Traveler’s Portfolio: 3 Stocks to Buy Now for Massive Returns by 2034
These long-term stocks to buy may seem speculative today, but so did Nvidia in 2024 -- and they may match the chipmaker's returns by 2034. 
Via InvestorPlace
DD Stock Separation Plan: What to Know as DuPont Splits Into 3 Companies
DD stock is eyeing some modest gains today after DuPont announced plans to split its electronics and water units from its core business. 
Via InvestorPlace
Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies
U.S. Supreme Court urged by Biden administration to reconsider terrorism funding ruling involving major pharmaceutical and medical equipment companies accused of supporting terrorism in Iraq. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Johnson & Johnson's Bankruptcy Tactics Are Fraudulent, Plaintiffs Accuse Company Of Defrauding Cancer Victims
Cancer victims have filed a lawsuit against Johnson & Johnson, accusing the company of fraudulently using a shell company's bankruptcy to evade lawsuits. The plaintiffs claim the "Texas two-step"... 
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Legal
Expert Ratings For Johnson & Johnson
Via Benzinga
Smart Money Is Betting Big In JNJ Options
Via Benzinga
Inquiry Into Johnson &amp; Johnson's Competitor Dynamics In Pharmaceuticals Industry
Via Benzinga
The 500 Top Stocks to Buy in May, According to AI
MarketMaster AI tells us that the top stocks to buy in May represent high-quality companies with strong fundamentals. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
7 Safe-Haven Stocks to Weather Any Storm
Explore top safe-haven stocks to buy now for stability and consistent growth during economic turbulence and uncertainty. 
Via InvestorPlace
7 Dividend Kings to Buy for Royal Passive Income: May Edition
Although they’re not the most exciting entities, these dividend kings to buy benefit from decades of proven performances. 
Via InvestorPlace
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Johnson & Johnson Stock
Johnson & Johnson is a high-quality dividend stock. 
Via The Motley Fool
The AI Stock Underdogs: 7 Underappreciated Companies Poised for Greatness
Although the usual suspects grab the digital intelligence headlines, these underappreciated AI stocks deserve a closer look. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why NYSE:JNJ is a Top Pick for Dividend Investors.
Is JOHNSON & JOHNSON (NYSE:JNJ) a Good Fit for Dividend Investing? 
Via Chartmill
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). 
Via Benzinga
Topics Cannabis
Exposures Cannabis
7 Value Stocks to Buy and Hold for a Decade of Dominance
Discover the enduring value of seven key value stocks to buy and hold in diverse sectors, presenting unparalleled opportunities. 
Via InvestorPlace
3 Cheap Healthcare Stocks to Buy Now: May 2024
Healthcare is cheaper than the market and has secular growth tailwinds, meaning these cheap healthcare stocks have upside. 
Via InvestorPlace
3 Robotics and Automation Stocks to Sell in May Before They Crash & Burn
Discover three robotics and automation stocks that face significant challenges, including market saturation and competitive pressures. 
Via InvestorPlace
Divide and Conquer: 3 Stock Spinoffs Set to Trounce the Market
The market often doesn't know what to make of them at first, giving savvy investors first crack at these stock spinoffs to buy. 
Via InvestorPlace
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Johnson & Johnson acquires Proteologix for $850 million, expanding its bispecific antibody portfolio for immune-mediated diseases. 
Via Benzinga
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France,... 
Via Benzinga
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
From Johnson & Johnson
Via Business Wire
Consumer Staples Standouts: 3 Defensive Gems to Safeguard Your Portfolio
These top consumer staples giants could be among the best ways for investors to retain defensive exposure in this current market. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
1 No-Brainer Growth Stock to Buy and Hold for 10 Years
This company's potential far outweighs its risks. 
Via The Motley Fool
Best Foundational Stocks
Building the foundation of investors portfolio with the best US foundational stocks by sector. 
Via Talk Markets
J&J: A Healthy Dose Of Income And Growth
Johnson & Johnson (JNJ)— founded in 1886 — is a diversified healthcare company and a leader in the area of innovative medicine and medical devices. 
Via Talk Markets
Johnson & Johnson's Subsidiary Discontinues Some Megadyne Electrodes For Pediatric Use
Johnson & Johnson's Megadyne Mega Soft Pediatric Patient Return Electrodes recalled due to patient burns. FDA's Class I recall impacts 21,200 devices. 
Via Benzinga
Exposures Product Safety
Johnson & Johnson Is Officially Getting Out of Kenvue (KVUE) Stock
Kenvue stock is up on Monday after Johnson & Johnson announced plans to sell its entire stake in KVUE following last year's spinoff. 
Via InvestorPlace
2 Supercharged Dividend Stocks to Buy and Hold for Years
Consistent passive income is one top goal long-term investors should have for their portfolio. 
Via The Motley Fool
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.